Genmab A/S (GMAB): key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2025)
- $3.7B
- Net Income/Loss (FY2025)
- $963.0M
- Total Assets (FY2025)
- $12.9B
- Total Equity (FY2025)
- $5.8B
- Cash Flows from Operating Activities (FY2025)
- $1.2B
Source: Genmab A/S annual_report filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
